Clinical Trials Directory

Trials / Completed

CompletedNCT05680675

Dual-Tracer Theranostic PET

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSingle-Tracer FDG PET/CT ExamThe PET technologist will administer approximately 15 millicuries (mCi) of FDG intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.
DIAGNOSTIC_TESTSingle-Tracer Cu64-DOTATATE PET/CT ExamThe PET technologist will administer with approximately 4 mCi Cu64-DOTATATE intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.
DIAGNOSTIC_TESTSingle-Tracer Ga68-DOTATATE PET/CT ExamThe PET technologist will administer with with approximately 5 mCi Ga68-DOTATATE intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.
DIAGNOSTIC_TESTSingle-Tracer PSMA PET/CT ExamThe PET technologist will administer with with approximately 7 mCi Ga68-PSMA-11 intravenously, and the participant will remain resting during the tracer uptake period. A CT topogram will be obtained, and the PET imaging field-of-view (FOV) selected. The PET scan will then be acquired, acquiring 5 back-to-back "whole-body" (eyes-to-thighs, or similar) scans, providing 5 sequential PET images.

Timeline

Start date
2022-12-08
Primary completion
2024-06-04
Completion
2024-06-04
First posted
2023-01-11
Last updated
2025-02-06
Results posted
2025-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05680675. Inclusion in this directory is not an endorsement.

Dual-Tracer Theranostic PET (NCT05680675) · Clinical Trials Directory